IRRAS USA Inc.

IRRAS USA Inc. is a medical device company that specializes in innovative solutions for neurocritical care. The company focuses on improving the management and outcomes of critically ill patients through advanced medical technologies. Their mission is to enhance patient care by addressing critical needs in managing brain injuries and other neurological conditions that require intensive monitoring and fluid control. IRRAS offers a range of integrated medical devices designed for automated fluid management and continuous intracranial pressure (ICP) monitoring. Key products include the Hummingbird ICPControl Module, which automates irrigation processes; the Hummingbird Solo for real-time ICP monitoring; and the Hummingbird Quad, which combines ICP monitoring with drainage capabilities. Their Active Fluid Exchange Technology allows for continuous and controlled fluid exchange, optimizing patient outcomes. The company primarily serves healthcare providers and institutions involved in neurocritical care, including hospitals and specialized neurological centers, providing tools that enhance decision-making and patient safety in critical care environments.

• Employees 48
• Founded 2012
• Annual Revenue $3577000
• Total Funding $33759435